What are the risks and side effects of hydroxychloroquine in adults with rheumatoid arthritis or lupus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxychloroquine Risks and Side Effects

Hydroxychloroquine is generally well-tolerated with a relatively low rate of drug-related adverse effects, but requires vigilant monitoring for retinopathy (the most serious long-term risk), cardiotoxicity with prolonged use, and common gastrointestinal symptoms. 1

Common and Mild Side Effects

  • Gastrointestinal symptoms (nausea, vomiting, diarrhea) are the most frequent adverse effects, accounting for most treatment intolerances, though these are usually mild and reversible. 1, 2

Serious Long-Term Toxicities

Retinopathy (Most Important Dose-Limiting Toxicity)

  • Retinopathy risk increases dramatically with duration of use: 0.5% after 6 years, 7.5% in long-term users generally, and exceeds 20% after 20 years of treatment. 3, 1
  • The risk remains less than 1% during the first 5 years when dosed at ≤5 mg/kg actual body weight daily, and less than 2% at 5-10 years with appropriate dosing. 1
  • Retinopathy may progress even after drug cessation if detected late, making early detection crucial. 1

Ophthalmologic Monitoring Requirements

  • No baseline ophthalmologic examination is required before initiating treatment. 3, 1
  • Begin annual screening after 1 year in high-risk patients (concomitant tamoxifen use, eGFR <60 ml/min/1.73 m², dose >5 mg/kg/day, or use of chloroquine). 3, 1
  • Begin annual screening after 5 years in standard-risk patients. 3, 1
  • Screening must include 10-2 visual field testing, spectral-domain OCT, and fundus autofluorescence. 1

Cardiotoxicity

  • Conduction abnormalities including heart block and QTc prolongation can occur, particularly with short-term use and when combined with other QTc-prolonging medications. 1, 2, 4
  • Cardiomyopathy manifesting as heart failure can develop with high cumulative exposure, typically after many years of use (20-30 years). 3, 1, 5
  • Some clinicians perform yearly ECGs in asymptomatic patients, especially with chloroquine use. 1
  • Cardiotoxicity may be reversible with early detection and prompt discontinuation of hydroxychloroquine. 5

Less Common but Important Side Effects

Hematologic

  • Risk of hemolysis in patients with G6PD deficiency exists, and G6PD levels should be measured before starting hydroxychloroquine in men, especially those of African, Asian, or Middle Eastern origin. 3, 1
  • However, this risk appears low according to recent reports. 3

Neuropsychiatric

  • Confusion, disorientation, and hallucinations may occur within 24-48 hours of drug initiation. 2
  • If hallucinations develop, hydroxychloroquine should be immediately discontinued. 6

Dermatologic

  • Drug eruptions, cutaneous hyperpigmentation, pruritis, Stevens-Johnson syndrome, and toxic epidermal necrolysis may occur within days to weeks but usually resolve with discontinuation. 2

Other Toxicities

  • Ototoxicity can occur when doses exceed 250 mg/day. 1
  • Rarely, neuromyotoxicity including myositis, muscle weakness, and pseudoparkinsonism have been reported with long-term use. 2

Critical Dosing Guidelines to Minimize Toxicity

  • The daily dose should not exceed 5 mg/kg actual body weight to minimize retinopathy risk. 3, 1
  • Doses of 2-3 mg/kg/day may not achieve adequate blood levels and are associated with higher flare rates. 3, 1
  • In patients with eGFR <30 ml/min/1.73 m², reduce the dose by 25%. 3, 1
  • Target blood hydroxychloroquine level should be >0.6 mg/L for optimal disease control. 3, 1

Overdose Toxicity

  • Symptoms manifest rapidly (within 1-3 hours) and cardiovascular collapse is most prominent, including QRS/QTc prolongation, ventricular arrhythmias, torsade de pointes, cardiac arrest, and death. 7, 2
  • Life-threatening hypotension is common in severe toxicity. 7
  • CNS depression, seizures, visual disturbances, and coma may occur. 7
  • Severe hypokalemia secondary to intracellular shift is common. 7

Important Drug Interactions

  • Hydroxychloroquine may enhance hypoglycemic effects of insulin and antidiabetic drugs, requiring dose reduction of these medications. 7
  • Concomitant use with digoxin may increase serum digoxin levels, requiring close monitoring. 7
  • Concomitant use with methotrexate may increase incidence of adverse reactions. 7
  • The activity of antiepileptic drugs might be impaired, and hydroxychloroquine can lower the seizure threshold. 7

Special Populations

  • Hydroxychloroquine is safe during pregnancy and is associated with decreased lupus activity without harm to the fetus. 1
  • The drug is present in human milk at low levels with no adverse reactions reported in breastfed infants. 7
  • In geriatric patients, start with the lowest recommended dose due to substantial renal excretion and greater risk of toxic reactions with impaired renal function. 7

References

Guideline

Hydroxychloroquine Side Effects and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

American College of Rheumatology White Paper on Antimalarial Cardiac Toxicity.

Arthritis & rheumatology (Hoboken, N.J.), 2021

Guideline

Hydroxychloroquine Therapy in Systemic Lupus Erythematosus

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the potential side effects of hydroxychloroquine and how can they be managed?
What are the potential interactions between hydroxychloroquine and doxycycline in a patient with an autoimmune condition, such as rheumatoid arthritis or lupus, and impaired renal function?
Should Plaquenil (hydroxychloroquine) be stopped prior to surgery in patients with a history of rheumatoid arthritis or lupus?
What treatment or further workup is recommended for a middle-aged or older adult patient with a 7-year history of Rheumatoid Arthritis (RA) taking plaquenil (hydroxychloroquine) who has developed dark spots on their back as a potential side effect of the medication?
Are there interactions between hydroxychloroquine and the following medications: Wellbutrin (bupropion), escitalopram, Adderall, Mounjaro (tirzepatide), Ubrelvy (ubrogepant)?
What does an elevated Erythrocyte Sedimentation Rate (ESR) indicate in a pregnant patient?
What is the most appropriate initial investigation for a 14-month-old baby presenting with an abdominal mass and calcification on abdominal x-ray?
What is the management approach for a patient with mild atheroma on computed tomography coronary angiography (CTCA)?
What is the treatment for a patient with sickle cell disease experiencing a vasoocclusive crisis?
What is the most appropriate initial treatment for the acid-base imbalance in a 20-year-old underweight woman with dyspnea, anion gap metabolic acidosis, impaired renal function, hyperkalemia, hyponatremia, and diabetic ketoacidosis, alongside IV fluids?
What is the best treatment approach for a patient with Attention Deficit Hyperactivity Disorder (ADHD) and conduct disorder?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.